1. Home
  2. ABCL vs CLOV Comparison

ABCL vs CLOV Comparison

Compare ABCL & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.97

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Clover Health Investments Corp.

CLOV

Clover Health Investments Corp.

HOLD

Current Price

$4.78

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
CLOV
Founded
2012
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ABCL
CLOV
Price
$5.97
$4.78
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$8.40
$2.90
AVG Volume (30 Days)
7.5M
6.9M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
38.03
EPS
N/A
0.05
Revenue
$75,128,000.00
$1,924,308,000.00
Revenue This Year
N/A
$52.59
Revenue Next Year
$21.85
$15.37
P/E Ratio
N/A
$90.00
Revenue Growth
160.56
40.34
52 Week Low
$2.75
$1.58
52 Week High
$8.44
$5.59

Technical Indicators

Market Signals
Indicator
ABCL
CLOV
Relative Strength Index (RSI) 44.40 53.27
Support Level $5.23 $1.96
Resistance Level $6.79 $5.18
Average True Range (ATR) 0.61 0.29
MACD -0.23 -0.09
Stochastic Oscillator 14.66 39.18

Price Performance

Historical Comparison
ABCL
CLOV

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Share on Social Networks: